Studies have revealed that the lymph node environment induces an IFN−γ–mediated state in metastatic cancer cells, promoting MHC−II expression and local regulatory T−cell expansion, highlighting a unique immune−modulatory niche in lymph nodes compared to primary tumors (23). Here, IFNG is linked to cancer.